[Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
D000328:Adult; D000368:Aged; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases / Q000517:prevention & control; D008140:Lorazepam / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000187:drug effects; D011619:Psychotropic Drugs / Q000009:adverse effects*; D011817:Rabbits; D012838:Silymarin / Q000494:pharmacology / Q000627:therapeutic use*
D005419:Flavonoids; D011619:Psychotropic Drugs; D012838:Silymarin; D008140:Lorazepam
Silimarina nella profilassi del danno epatico da psicofarmaci. Premesse sperimentali e valutazioni cliniche.